अब आप न्यूज्ड हिंदी में पढ़ सकते हैं।यहाँ क्लिक करें
Home » Budget 2026 » Budget 2026 proposes Rs 10,000 cr investment in biopharma over next 5 years

Budget 2026 proposes Rs 10,000 cr investment in biopharma over next 5 years

Biopharmaceuticals, or biologics, are complex medicines manufactured from living organisms, cells, or tissues rather than through chemical synthesis.

By Newsd
Publishedon :
Govt to launch Rs 2-cr term loan for 5 lakh first-time women, SC, ST entrepreneurs: FM, India’s Union Budget 2026 February 1

Finance Minister Nirmala Sitharaman on Sunday proposed Rs 10,000 crore investment in the biopharma sector over the next five years, a move which would give a boost to the country’s pharmaceuticals industry.

Biopharmaceuticals, or biologics, are complex medicines manufactured from living organisms, cells, or tissues rather than through chemical synthesis. She also proposed interventions in six areas, including manufacturing, strategic and frontier sectors, healthcare and advanced technology.

The minister added that semiconductor mission 2.0 will focus on producing equipment and materials designed for full-stack Indian IP (intellectual property).

The India Semiconductor Mission (ISM) is a specialized, autonomous business division within Digital India Corporation under Ministry of Electronics and Information Technology (MeitY), designed to build a sustainable semiconductor and display ecosystem.

Sitharaman also announced support for mineral rich states of Odisha, Kerala, Andhra Pradesh and Tamil Nadu to establish critical mineral facilities. She added that ‘Sabka Saath, Sabka Vikas’ is the third Kartavya of the government.

Related

Latests Posts


Editor's Choice


Trending